TFFVIIaCa2

TFFVIIaCa2 is a term used to denote the complex formed by tissue factor (TF), activated factor VII (FVIIa), and calcium ions (Ca2+) on a phospholipid surface. This ternary complex acts as a principal initiator of the extrinsic coagulation pathway, linking vascular injury to the rapid generation of thrombin.

Formation and components

Tissue factor is a transmembrane receptor expressed by subendothelial cells and various tissues, while FVIIa is the activated serine protease form of factor VII. In the presence of Ca2+ and a negatively charged phospholipid surface, TF binds FVIIa to form the TF-FVIIa-Ca2+ complex. Calcium ions are essential for the proper arrangement of binding sites and for anchoring the complex to membrane surfaces.

Mechanism of action

The TF-FVIIa-Ca2+ complex proteolytically activates factor X to Xa and factor IX to IXa, initiating the generation of thrombin from prothrombin. This thrombin then cleaves fibrinogen to fibrin, promoting clot formation. The activity is enhanced on anionic phospholipid surfaces provided by activated platelets or cellular microvesicles, which concentrate coagulation factors and facilitate substrate proximity.

Regulation

TF activity is tightly regulated by inhibitors such as tissue factor pathway inhibitor (TFPI), which forms a quaternary complex with TF-FVIIa and Xa. The activity of FVIIa and TF is also influenced by overall vitamin K–dependent carboxylation of coagulation factors and by endogenous anticoagulant pathways, including antithrombin and the protein C system.

Clinical relevance

Dysregulation of the TF-FVIIa-Ca2+ system can contribute to bleeding disorders or thrombosis. It is a focal point in research on anticoagulation strategies and in understanding inflammatory states where TF expression is upregulated, such as sepsis or atherosclerosis.